ONS Written Comments to the FDA
Friday, June 26, 2009
ONS submitted written comments to the Food and Drug Administration (FDA) related to the possibility that the FDA will create a Risk Evaluation and Mitigation Strategies (REMS) for certain opioid drugs.
ONS Written Comments to the FDA on a possible REMS for Opioids
